Objectives Understanding the molecular changes in the preclinical synovium is crucial for identifying factors that drive ...

Objective Transcortical pores and the bare area have been suggested as structural determinants of bone erosions in rheumatoid ...

Objective The aim of this study was to investigate the relationship between antineutrophil cytoplasmic antibodies (ANCA) ...

Objectives The TREAT EARLIER trial showed in clinically suspect arthralgia (CSA) that methotrexate induced reductions in ...

Objective Sjögren’s is a chronic systemic autoimmune disease characterised by dryness symptoms (eyes, mouth, skin), alongside ...

Objective Insomnia often co-exists with hip or knee pain and is associated with greater pain severity. However, there is ...

Background Chronic pain due to osteoarthritis (OA) causes considerable burden, and current treatment options are limited. This phase III study aimed to compare the efficacy and safety of fasinumab, an ...

on behalf of the EULAR Sjögren's Task Force 1 2 3 4 5 6 7 8 9 10 11 on behalf of the EULAR Sjögren's Task Force. The EULAR Sjögren's syndrome (SS) disease activity ...

Background About 20% of female patients with anti-phospholipid syndrome (APS) experience obstetric complications despite standard treatment with aspirin and heparin. Treatment with hydroxychloroquine ...

Objective To examine the performance of the new 2022 American College of Rheumatology (ACR)/EULAR giant cell arteritis (GCA) classification criteria for diagnosis in routine clinical care. Methods ...

Background Systemic sclerosis (SSc) is a severe, progressive multiorgan disease but to date, there are no established standardised international guidelines for follow-up of patients with SSc. The goal ...